investment

Perstorp proceeds with UK Caprolactone Upgrad

Jennewein Biotechnologie to Build New R&D Centre

Tatarstan - a Hot Spot of the Chemical Industry in Russia

Lonza Expands in US, Moves Some Production

Finland Relinquishes Control of Neste

Venezuela: Plenty of Room for Improvement

Swiss Biotech Sector Stimulates Growth

Business Opportunities in the US

Trade and Industry Investment of the US Chemical Sector

UK Chemical Companies Start to Fear the Worst with Brexit

Ireland’s Thriving Pharma and Chemicals Producers Optimistic about Brexit

The Italian Chemical Industry

Green Chemistry and Smart Chemistry

Regaining Competitiveness in the Global Market

Oman Oil Company and Kuwait Petroleum to Co-develop Duqm Refinery

ADC Bio to Invest $11m on Bioconjugation Facility

Taiwan Chemical Firms to Expand at Daesan

CordenPharma Expands Manufacturing Capacities for Veterinary Drug Products

Adnoc Seeks Partners on Stronger Petchems Focus

Arkema Outlines Forward-looking Goals

A Future-oriented Industrial Policy Strategy

Sibur Plans Plasticizer Plant in Perm, Russia

Kemira Expands Sizing Agents in China

Taiwan’s CPC Looks to Invest in US Shale

Ineos Plans Major Olefins Projects in Europe

Lubrizol Hikes Drug Product Manufacturing Capacity

Eastman Expands US Films Capacity

Kazakhstan and UAE Link on PE Project

Iran: Rediscovering a Sleeping Giant

China’s Wanhua Plans MDI Complex in Louisiana

Chinese Firms Eye Chemicals JVs in Pakistan

Akzo Nobel Invests in UK Innovation Hub

Germany’s AlzChem Postpones IPO

A Visible Turning Point for Oxea

Ten years ago, in March 2007, oxo chemicals producer Oxea was established as a buyout led by private-equity firm Advent International of oxo derivatives and oxo intermediates businesses from Celanese and European Oxo.

Pfizer and TVM Life Science Ventures Invest in Ixchelsis